|
2024-09-12 |
2024-09-11 |
S
Sale
|
Jalota Deepika
Chief Development Officer
Officer
|
7,218
-5.8%
1.50
USD 10,853
|
7,218
-5.8%
|
1.50
|
USD 10,853
|
|
|
2024-09-12 |
2024-09-11 |
S
Sale
|
Carulli Michael
Chief Financial Officer
Officer
|
2,891
-3.2%
1.50
USD 4,347
|
2,891
-3.2%
|
1.50
|
USD 4,347
|
|
|
2023-11-24 |
2023-11-22 |
S
Sale
|
ORBIMED ADVISORS LLC
Large shareholder
|
87,786
-100.0%
2.23
USD 195,763
|
87,786
-100.0%
|
2.23
|
USD 195,763
|
|
|
2023-09-18 |
2023-09-15 |
S
Sale
|
Alland Leila
Chief Medical Officer
Officer
|
6,291
-12.1%
6.62
USD 41,646
|
6,291
-12.1%
|
6.62
|
USD 41,646
|
|
|
2023-09-18 |
2023-09-15 |
S
Sale
|
Jalota Deepika
Chief Development Officer
Officer
|
4,104
-12.1%
6.62
USD 27,168
|
4,104
-12.1%
|
6.62
|
USD 27,168
|
|
|
2022-05-31 |
2022-05-26 |
S
Sale
|
ORBIMED ADVISORS LLC
Large shareholder
|
26,253
-23.0%
15.93
USD 418,210
|
26,253
-23.0%
|
15.93
|
USD 418,210
|
|
|
2021-10-08 |
2021-10-06 |
PS
Planned sale
|
Schroeder Thilo
Non-Executive Director
|
800
-0.1%
30.15
USD 24,120
|
800
-0.1%
|
30.15
|
USD 24,120
|
|
|
2021-10-04 |
2021-10-04 |
PS
Planned sale
|
Schroeder Thilo
Non-Executive Director
|
100
-0.0%
30.08
USD 3,008
|
100
-0.0%
|
30.08
|
USD 3,008
|
|
|
2021-10-04 |
2021-10-01 |
PS
Planned sale
|
Schroeder Thilo
Non-Executive Director
|
11,541
-1.0%
30.10
USD 347,384
|
11,541
-1.0%
|
30.10
|
USD 347,384
|
|
|
2021-10-04 |
2021-09-30 |
PS
Planned sale
|
Schroeder Thilo
Non-Executive Director
|
2,978
-0.3%
30.03
USD 89,429
|
2,978
-0.3%
|
30.03
|
USD 89,429
|
|
|
2021-09-29 |
2021-09-29 |
PS
Planned sale
|
Schroeder Thilo
Non-Executive Director
|
5,708
-0.5%
30.04
USD 171,468
|
5,708
-0.5%
|
30.04
|
USD 171,468
|
|
|
2021-09-29 |
2021-09-27 |
PS
Planned sale
|
Schroeder Thilo
Non-Executive Director
|
1,753
-0.2%
30.11
USD 52,783
|
1,753
-0.2%
|
30.11
|
USD 52,783
|
|
|
2021-09-13 |
2021-09-13 |
PS
Planned sale
|
Schroeder Thilo
Non-Executive Director
|
13,272
-1.2%
30.20
USD 400,814
|
13,272
-1.2%
|
30.20
|
USD 400,814
|
|
|
2021-09-13 |
2021-09-10 |
PS
Planned sale
|
Schroeder Thilo
Non-Executive Director
|
5,171
-0.5%
31.03
USD 160,456
|
5,171
-0.5%
|
31.03
|
USD 160,456
|
|
|
2021-09-13 |
2021-09-10 |
PS
Planned sale
|
Schroeder Thilo
Non-Executive Director
|
38,056
-3.2%
30.44
USD 1,158,425
|
38,056
-3.2%
|
30.44
|
USD 1,158,425
|
|
|
2021-09-13 |
2021-09-09 |
PS
Planned sale
|
Schroeder Thilo
Non-Executive Director
|
14,329
-1.2%
30.31
USD 434,312
|
14,329
-1.2%
|
30.31
|
USD 434,312
|
|
|
2021-08-20 |
2021-08-19 |
PS
Planned sale
|
Schroeder Thilo
Non-Executive Director
|
3,800
-0.2%
30.97
USD 117,686
|
3,800
-0.2%
|
30.97
|
USD 117,686
|
|
|
2021-08-20 |
2021-08-18 |
PS
Planned sale
|
Schroeder Thilo
Non-Executive Director
|
2,237
-0.1%
34.32
USD 76,774
|
2,237
-0.1%
|
34.32
|
USD 76,774
|
|
|
2021-08-20 |
2021-08-18 |
PS
Planned sale
|
Schroeder Thilo
Non-Executive Director
|
13,196
-0.8%
33.84
USD 446,553
|
13,196
-0.8%
|
33.84
|
USD 446,553
|
|
|
2021-08-20 |
2021-08-18 |
PS
Planned sale
|
Schroeder Thilo
Non-Executive Director
|
11,431
-0.7%
32.57
USD 372,308
|
11,431
-0.7%
|
32.57
|
USD 372,308
|
|
|
2021-08-04 |
2021-08-03 |
PS
Planned sale
|
Kung Winston
COO, CFO
Officer
|
4,500
-73.8%
33.82
USD 152,178
|
4,500
-73.8%
|
33.82
|
USD 152,178
|
|
|
2021-07-08 |
2021-07-08 |
PS
Planned sale
|
Kung Winston
COO, CFO
Officer
|
4,500
-73.8%
33.75
USD 151,875
|
4,500
-73.8%
|
33.75
|
USD 151,875
|
|
|
2021-06-29 |
2021-06-28 |
PS
Planned sale
|
Mack David Henry
President and CEO
Executive Director
|
204
-1.6%
35.53
USD 7,248
|
204
-1.6%
|
35.53
|
USD 7,248
|
|
|
2021-06-15 |
2021-06-14 |
S
Sale
|
Euclidean Capital LLC
Large shareholder
|
1,260
-1.0%
34.11
USD 42,979
|
1,260
-1.0%
|
34.11
|
USD 42,979
|
|
|
2021-06-15 |
2021-06-14 |
S
Sale
|
Euclidean Capital LLC
Large shareholder
|
24,726
-1.0%
34.11
USD 843,404
|
24,726
-1.0%
|
34.11
|
USD 843,404
|
|
|
2021-06-15 |
2021-06-14 |
S
Sale
|
Euclidean Capital LLC
Large shareholder
|
7,141
-1.0%
34.11
USD 243,580
|
7,141
-1.0%
|
34.11
|
USD 243,580
|
|
|
2021-06-15 |
2021-06-14 |
S
Sale
|
Euclidean Capital LLC
Large shareholder
|
6,593
-1.0%
34.11
USD 224,887
|
6,593
-1.0%
|
34.11
|
USD 224,887
|
|
|
2021-06-15 |
2021-06-14 |
S
Sale
|
Euclidean Capital LLC
Large shareholder
|
4,699
-1.0%
34.11
USD 160,283
|
4,699
-1.0%
|
34.11
|
USD 160,283
|
|
|
2021-06-15 |
2021-06-11 |
S
Sale
|
Euclidean Capital LLC
Large shareholder
|
621
-0.5%
33.80
USD 20,990
|
621
-0.5%
|
33.80
|
USD 20,990
|
|
|
2021-06-15 |
2021-06-11 |
S
Sale
|
Euclidean Capital LLC
Large shareholder
|
12,237
-0.5%
33.80
USD 413,611
|
12,237
-0.5%
|
33.80
|
USD 413,611
|
|
|
2021-06-15 |
2021-06-11 |
S
Sale
|
Euclidean Capital LLC
Large shareholder
|
3,533
-0.5%
33.80
USD 119,415
|
3,533
-0.5%
|
33.80
|
USD 119,415
|
|
|
2021-06-15 |
2021-06-11 |
S
Sale
|
Euclidean Capital LLC
Large shareholder
|
3,262
-0.5%
33.80
USD 110,256
|
3,262
-0.5%
|
33.80
|
USD 110,256
|
|
|
2021-06-15 |
2021-06-11 |
S
Sale
|
Euclidean Capital LLC
Large shareholder
|
2,324
-0.5%
33.80
USD 78,551
|
2,324
-0.5%
|
33.80
|
USD 78,551
|
|
|
2021-06-11 |
2021-06-10 |
S
Sale
|
Euclidean Capital LLC
Large shareholder
|
585
-0.4%
32.68
USD 19,118
|
585
-0.4%
|
32.68
|
USD 19,118
|
|
|
2021-06-11 |
2021-06-10 |
S
Sale
|
Euclidean Capital LLC
Large shareholder
|
11,485
-0.5%
32.68
USD 375,330
|
11,485
-0.5%
|
32.68
|
USD 375,330
|
|
|
2021-06-11 |
2021-06-10 |
S
Sale
|
Euclidean Capital LLC
Large shareholder
|
3,317
-0.5%
32.68
USD 108,400
|
3,317
-0.5%
|
32.68
|
USD 108,400
|
|
|
2021-06-11 |
2021-06-10 |
S
Sale
|
Euclidean Capital LLC
Large shareholder
|
3,063
-0.5%
32.68
USD 100,099
|
3,063
-0.5%
|
32.68
|
USD 100,099
|
|
|
2021-06-11 |
2021-06-10 |
S
Sale
|
Euclidean Capital LLC
Large shareholder
|
2,183
-0.5%
32.68
USD 71,340
|
2,183
-0.5%
|
32.68
|
USD 71,340
|
|
|
2021-06-11 |
2021-06-09 |
S
Sale
|
Euclidean Capital LLC
Large shareholder
|
1,121
-0.9%
33.64
USD 37,710
|
1,121
-0.9%
|
33.64
|
USD 37,710
|
|
|
2021-06-11 |
2021-06-09 |
S
Sale
|
Euclidean Capital LLC
Large shareholder
|
22,070
-0.9%
33.64
USD 742,435
|
22,070
-0.9%
|
33.64
|
USD 742,435
|
|
|
2021-06-11 |
2021-06-09 |
S
Sale
|
Euclidean Capital LLC
Large shareholder
|
6,372
-0.9%
33.64
USD 214,354
|
6,372
-0.9%
|
33.64
|
USD 214,354
|
|
|
2021-06-11 |
2021-06-09 |
S
Sale
|
Euclidean Capital LLC
Large shareholder
|
5,883
-0.9%
33.64
USD 197,904
|
5,883
-0.9%
|
33.64
|
USD 197,904
|
|
|
2021-06-11 |
2021-06-09 |
S
Sale
|
Euclidean Capital LLC
Large shareholder
|
4,192
-0.9%
33.64
USD 141,019
|
4,192
-0.9%
|
33.64
|
USD 141,019
|
|
|
2021-06-09 |
2021-06-08 |
S
Sale
|
Euclidean Capital LLC
Large shareholder
|
896
-0.7%
33.38
USD 29,908
|
896
-0.7%
|
33.38
|
USD 29,908
|
|
|
2021-06-09 |
2021-06-08 |
S
Sale
|
Euclidean Capital LLC
Large shareholder
|
17,664
-0.7%
33.38
USD 589,624
|
17,664
-0.7%
|
33.38
|
USD 589,624
|
|
|
2021-06-09 |
2021-06-08 |
S
Sale
|
Euclidean Capital LLC
Large shareholder
|
5,101
-0.7%
33.38
USD 170,271
|
5,101
-0.7%
|
33.38
|
USD 170,271
|
|
|
2021-06-09 |
2021-06-08 |
S
Sale
|
Euclidean Capital LLC
Large shareholder
|
4,708
-0.7%
33.38
USD 157,153
|
4,708
-0.7%
|
33.38
|
USD 157,153
|
|
|
2021-06-09 |
2021-06-08 |
S
Sale
|
Euclidean Capital LLC
Large shareholder
|
3,355
-0.7%
33.38
USD 111,990
|
3,355
-0.7%
|
33.38
|
USD 111,990
|
|
|
2021-06-09 |
2021-06-07 |
S
Sale
|
Euclidean Capital LLC
Large shareholder
|
1,019
-0.8%
33.62
USD 34,259
|
1,019
-0.8%
|
33.62
|
USD 34,259
|
|
|
2021-06-09 |
2021-06-07 |
S
Sale
|
Euclidean Capital LLC
Large shareholder
|
16,901
-0.6%
33.62
USD 568,212
|
16,901
-0.6%
|
33.62
|
USD 568,212
|
|
|
2021-06-09 |
2021-06-07 |
S
Sale
|
Euclidean Capital LLC
Large shareholder
|
4,946
-0.7%
33.62
USD 166,285
|
4,946
-0.7%
|
33.62
|
USD 166,285
|
|
|
2021-06-09 |
2021-06-07 |
S
Sale
|
Euclidean Capital LLC
Large shareholder
|
4,564
-0.7%
33.62
USD 153,442
|
4,564
-0.7%
|
33.62
|
USD 153,442
|
|
|
2021-06-09 |
2021-06-07 |
S
Sale
|
Euclidean Capital LLC
Large shareholder
|
3,291
-0.7%
33.62
USD 110,643
|
3,291
-0.7%
|
33.62
|
USD 110,643
|
|
|
2021-06-08 |
2021-06-07 |
PS
Planned sale
|
Alland Leila
Chief Medical Officer
Officer
|
1,367
-100.0%
34.00
USD 46,484
|
1,367
-100.0%
|
34.00
|
USD 46,484
|
|
|
2021-06-08 |
2021-06-07 |
PS
Planned sale
|
Alland Leila
Chief Medical Officer
Officer
|
2,633
-65.8%
33.39
USD 87,903
|
2,633
-65.8%
|
33.39
|
USD 87,903
|
|
|
2021-06-07 |
2021-06-04 |
PS
Planned sale
|
Kung Winston
COO, CFO
Officer
|
4,500
-73.8%
33.75
USD 151,875
|
4,500
-73.8%
|
33.75
|
USD 151,875
|
|
|
2021-06-02 |
2021-06-01 |
PS
Planned sale
|
Heyman Richard A.
Non-Executive Director
|
2
-100.0%
34.67
USD 69
|
2
-100.0%
|
34.67
|
USD 69
|
|
|
2021-06-02 |
2021-06-01 |
PS
Planned sale
|
Heyman Richard A.
Non-Executive Director
|
209
-99.1%
33.79
USD 7,062
|
209
-99.1%
|
33.79
|
USD 7,062
|
|
|
2021-06-02 |
2021-06-01 |
PS
Planned sale
|
Heyman Richard A.
Non-Executive Director
|
764
-78.4%
32.15
USD 24,563
|
764
-78.4%
|
32.15
|
USD 24,563
|
|
|
2021-06-02 |
2021-06-01 |
PS
Planned sale
|
Heyman Richard A.
Non-Executive Director
|
2
-100.0%
34.67
USD 69
|
2
-100.0%
|
34.67
|
USD 69
|
|
|
2021-06-02 |
2021-06-01 |
PS
Planned sale
|
Heyman Richard A.
Non-Executive Director
|
230
-99.1%
33.75
USD 7,762
|
230
-99.1%
|
33.75
|
USD 7,762
|
|
|
2021-06-02 |
2021-06-01 |
PS
Planned sale
|
Heyman Richard A.
Non-Executive Director
|
743
-76.2%
32.16
USD 23,896
|
743
-76.2%
|
32.16
|
USD 23,896
|
|
|
2021-06-02 |
2021-06-01 |
PS
Planned sale
|
Heyman Richard A.
Non-Executive Director
|
5
-100.0%
34.67
USD 173
|
5
-100.0%
|
34.67
|
USD 173
|
|
|
2021-06-02 |
2021-06-01 |
PS
Planned sale
|
Heyman Richard A.
Non-Executive Director
|
553
-99.1%
33.61
USD 18,587
|
553
-99.1%
|
33.61
|
USD 18,587
|
|
|
2021-06-02 |
2021-06-01 |
PS
Planned sale
|
Heyman Richard A.
Non-Executive Director
|
1,392
-71.4%
32.15
USD 44,754
|
1,392
-71.4%
|
32.15
|
USD 44,754
|
|
|
2021-06-02 |
2021-05-28 |
PS
Planned sale
|
Schroeder Thilo
Non-Executive Director
|
5,100
-0.2%
35.80
USD 182,580
|
5,100
-0.2%
|
35.80
|
USD 182,580
|
|
|
2021-05-24 |
2021-05-21 |
PS
Planned sale
|
Mack David Henry
President and CEO
Executive Director
|
6,207
-71.5%
35.71
USD 221,641
|
6,207
-71.5%
|
35.71
|
USD 221,641
|
|
|
2021-05-24 |
2021-05-20 |
PS
Planned sale
|
Mack David Henry
President and CEO
Executive Director
|
7,793
-75.9%
35.60
USD 277,455
|
7,793
-75.9%
|
35.60
|
USD 277,455
|
|
|
2021-05-10 |
2021-05-07 |
PS
Planned sale
|
Alland Leila
Chief Medical Officer
Officer
|
158
-100.0%
35.49
USD 5,607
|
158
-100.0%
|
35.49
|
USD 5,607
|
|
|
2021-05-10 |
2021-05-07 |
PS
Planned sale
|
Alland Leila
Chief Medical Officer
Officer
|
3,842
-96.0%
34.80
USD 133,702
|
3,842
-96.0%
|
34.80
|
USD 133,702
|
|
|
2021-05-07 |
2021-05-05 |
PS
Planned sale
|
Schroeder Thilo
Non-Executive Director
|
600
-0.0%
35.64
USD 21,384
|
600
-0.0%
|
35.64
|
USD 21,384
|
|
|
2021-05-04 |
2021-05-03 |
PS
Planned sale
|
Kung Winston
COO, CFO
Officer
|
4,500
-73.8%
33.75
USD 151,875
|
4,500
-73.8%
|
33.75
|
USD 151,875
|
|
|
2021-04-13 |
2021-04-12 |
PS
Planned sale
|
Schroeder Thilo
Non-Executive Director
|
100
-0.0%
33.11
USD 3,311
|
100
-0.0%
|
33.11
|
USD 3,311
|
|
|
2021-04-13 |
2021-04-12 |
PS
Planned sale
|
Schroeder Thilo
Non-Executive Director
|
900
-0.0%
32.00
USD 28,800
|
900
-0.0%
|
32.00
|
USD 28,800
|
|
|
2021-04-13 |
2021-04-12 |
PS
Planned sale
|
Schroeder Thilo
Non-Executive Director
|
2,903
-0.1%
31.17
USD 90,487
|
2,903
-0.1%
|
31.17
|
USD 90,487
|
|
